Nazim Demircan, Associate Professor of Medical Oncology at Marmara university, shared on LinkedIn:
“Building Stronger Evidence for Rare Solid Tumors
Our Research Topic in Frontiers-Oncology remains open for contributions:
‘𝘌𝘷𝘪𝘥𝘦𝘯𝘤𝘦 𝘢𝘯𝘥 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘋𝘦𝘤𝘪𝘴𝘪𝘰𝘯-𝘔𝘢𝘬𝘪𝘯𝘨 𝘪𝘯 𝘙𝘢𝘳𝘦 𝘚𝘰𝘭𝘪𝘥 𝘛𝘶𝘮𝘰𝘳𝘴: 𝘊𝘩𝘢𝘭𝘭𝘦𝘯𝘨𝘦𝘴, 𝘊𝘶𝘳𝘳𝘦𝘯𝘵 𝘗𝘳𝘢𝘤𝘵𝘪𝘤𝘦, 𝘢𝘯𝘥 𝘍𝘶𝘵𝘶𝘳𝘦 𝘋𝘪𝘳𝘦𝘤𝘵𝘪𝘰𝘯𝘴’
Together with Topic Editors Herbert Loong, and Salvatore Provenzano, we welcome research addressing evidence generation and synthesis, real-world data, innovative clinical trial designs, molecular and multidisciplinary decision-making, and challenges in rare cancer care.
We look forward to bringing together diverse perspectives and research that can help improve clinical decisions in rare solid tumors.
Manuscript submission deadline: 30 March 2027.
Other articles about Nazim Demircan on OncoDaily.